Navigation Links
Study reveals a mechanism for mate selection
Date:4/18/2010

by stem cells during embryonic development and become dysfunctional in cancers."

Using yeast enabled the research to show how a cell might make important decisions. When yeast cells decide to mate, they must know that there is a mating partner close enough, and then make a snap decision to get ready to mate", says first author and graduate student Mohan Malleshaiah. Their decision to mate is not just fast, but precise, resulting in their selection of the best available partner, even though there may be many competing potential mates near by," Malleshaiah says. "Charles Darwin first discovered the principles governing how and why organisms choose mating partner 150 years ago. It is fascinating to see that the same principles that Darwin described to explain why a lioness chooses the strongest lion or a peahen chooses a peacock that has the most beautiful plumage can be so clearly observed at a molecular level in yeast," Malleshaiah adds.

Thanks to this Nature study, scientists have captured a glimpse of how cells make critical decisions about their fate. "Perhaps in the near future we may look forward to more discoveries of such switching mechanisms, with the potential of understanding and predicting how humans emerge from the complex process of cells deciding to become different tissues during development and how these decision-making switches break down in diseases," says Dr. Michnick.


'/>"/>

Contact: Sylvain-Jacques Desjardins
sylvain-jacques.desjardins@umontreal.ca
514-343-7593
University of Montreal
Source:Eurekalert

Page: 1 2

Related biology news :

1. Study pins factors behind geography of human disease
2. Global study shows health joins green as business strategy
3. U of I study: Lack of omega-3 fatty acid linked to male infertility
4. U of I study: Lack of omega-6 fatty acid linked to severe dermatitis
5. McMaster study unveils lifeline for antibiotic of last resort
6. FSU marine ecologist wins grant to study endangered sawfish
7. Pitt-led international study identifies human enzyme that breaks down potentially toxic nanomaterials, opens door to novel drug delivery
8. Pitt-led study identifies human enzyme that breaks down potentially toxic nanomaterials
9. BUSPH study links rheumatoid arthritis to vitamin D deficiency
10. 4,000-year study supports use of prescribed burns in Southern Appalachians
11. New study shows rising water temperatures in US streams and rivers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... 26, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... http://www.nxt-id.com/ ) as part of its 2015 marketing and ... launched its new consumer website for Wocketwallet.com earlier this ... of NXT-ID said, "Our new corporate website naturally showcases ...
(Date:2/5/2015)... Jan. 28, 2015 Research and Markets ... of the "Global Biometrics Market (2014-2020): Market ... Countries " report to their offering. , ... Asia-Pacific is anticipated to overtake ... to increasing government spending towards IT security, government ...
(Date:1/22/2015)... CHICAGO , Jan. 9, 2015 Valid S.A. ("Company") ... the market in general the State of Washington,s ... contract for a new enrollment and central issuance system for ... The project planning and development will start ...
Breaking Biology News(10 mins):NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3Valid USA Signs Contract For Washington Driver's License Issuance 2
... The next big thing in medical diagnostics could ... the material from which sand is formed, silicon dioxide. ... 230 nanometers across, can be used to trap antibodies ... the bacteria that causes potentially lethal diarrhea. According ...
... current check for kidney disease is a simple blood test ... days for this metabolite to accumulate to levels that are ... it may be too late to intervene. To close ... scientists and physicians led by Dr. Jonathan Barasch, M.D., Ph.D., ...
... few better-known proteins than nestin, whose very presence in an ... a neural stem cell. As helpful as this is to ... in a cell. In a study published in the ... , Salk Institute of Biological Studies investigators led by Kuo-Fen ...
Cached Biology News:Detecting lethal diseases with rust and sand 2Seeing kidney injury, as it happens 2Salk researchers discover that stem cell marker regulates synapse formation 2Salk researchers discover that stem cell marker regulates synapse formation 3
(Date:2/27/2015)...  Pharmacyclics, Inc. (NASDAQ: PCYC ) ... newly developed Bruton,s tyrosine kinase (BTK) inhibitor for ... results of these preclinical evaluations have been communicated ... feedback received from the Agency is supportive of ... preclinical work is required to begin a Phase ...
(Date:2/27/2015)... Bionomics Limited (ASX:BNO, ADR:BMICY) is to present ... in patients with metastatic renal cancer at the ASCO ... . The data will be presented by Dr. ... Cancer Center in California in ... identifies Ferritin and IL-8 as two baseline biomarkers that ...
(Date:2/27/2015)... Feb. 27, 2015   PureTech , a science ... commercializing disruptive products and technologies in the healthcare sector, ... former CEO and Member of the Board of Directors ... "It,s has been a pleasure to know Chris ... we will be working together more closely now," said ...
(Date:2/26/2015)... Feb. 26, 2015   Synageva BioPharma Corp. ... company developing therapeutic products for rare disorders, today ... 2015 goals, other key objectives, and financial guidance.  ... today at 4:30 p.m. EST to review the ... To participate in today,s call by telephone, please ...
Breaking Biology Technology:Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9
... LONDON, June 26, 2011 The pharmaceutical industry spent less on ... three years, according to data released today from the 2011 ... Thomson Reuters business. Key highlights from the ... new molecular entities (NMEs) were launched on the global market in ...
... 2011 Cebix Incorporated announced today that preclinical data ... (CBX129801), demonstrated a half-life of three days as compared ... impairment in nerve conduction velocity, a measure of the ... in an animal model of diabetic peripheral neuropathy. Additionally, ...
... Netherlands, June 24, 2011 /PRNewswire-iReach/ -- ...  announced today the completion of a non-exclusive research ... ("Lilly"), a global pharmaceutical company, to generate and ... light chains(H2L2) using one of Harbour,s transgenic mouse ...
Cached Biology Technology:Drug Dropout in Clinical Trials Is at Unsustainable Levels, According to Thomson Reuters, CMR International 2Drug Dropout in Clinical Trials Is at Unsustainable Levels, According to Thomson Reuters, CMR International 3Cebix's Long-Acting C-Peptide Ersatta™ has Potential in Multiple Chronic Complications of Diabetes 2Cebix's Long-Acting C-Peptide Ersatta™ has Potential in Multiple Chronic Complications of Diabetes 3Harbour Antibodies BV Signs Research and Licence Agreement With Lilly 2
Collected from sexually mature, mixed sex, mixed breed guinea pigs. Pricing: $120/unit for 1 - 10 units...
SEQUENASE PCR PRODUCT PRE-SEQU, 1 EA. Category: SEQUENASE....
Mouse monoclonal [IFR0104] to Salmonella enteriditis ( Abpromise for all tested applications)....
All serum is collected from adult animals aged 6 months or older. Certified U.S. orgin. Pricing: $35/unit for 1 - 10 units...
Biology Products: